Oncology Institute Inc) 

$0.05
37
+$0+4.91% Wednesday 19:44

Statistics

Day High
0.05
Day Low
0.04
52W High
0.05
52W Low
0.04
Volume
1,780
Avg. Volume
-
Mkt Cap
4.52M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

13MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.21
-0.16
-0.11
-0.06
Expected EPS
-0.0775
Actual EPS
N/A

Financials

-16.44%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
786.82MRevenue
-129.33MNet Income

Analyst Ratings

$6.67Average Price Target
The highest estimate is 8.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TOIIW. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Guardant Health
GH
Mkt Cap11.72B
Guardant Health offers liquid biopsies and genomic testing for cancer, directly competing in the oncology diagnostics space with TOI.
Exact Sciences
EXAS
Mkt Cap12.25B
Exact Sciences provides cancer screening and diagnostic tests, including for colorectal cancer, competing in the oncology diagnostics market.
Fulgent Genetics
FLGT
Mkt Cap687.17M
Fulgent Genetics offers comprehensive genetic testing, including for cancer, competing in the genetic testing space relevant to oncology.
Myriad Genetics
MYGN
Mkt Cap748.08M
Myriad Genetics specializes in molecular diagnostic tests, including for cancer, making it a direct competitor in the oncology diagnostic testing market.
Bio-Rad Laboratories
BIO
Mkt Cap8.54B
Bio-Rad Laboratories provides a range of products for the life science research and clinical diagnostics markets, including cancer research, making it a competitor.
Quest Diagnostics
DGX
Mkt Cap19.57B
Quest Diagnostics offers diagnostic testing services, including for cancer, competing in the healthcare diagnostics market.
Labcorp
LH
Mkt Cap21.08B
LabCorp provides health diagnostics, including for oncology, making it a competitor in the diagnostic services market.
Natera
NTRA
Mkt Cap27.3B
Natera offers genetic testing and diagnostics, including in the oncology space, competing in the genetic testing market for cancer.
Illumina
ILMN
Mkt Cap18.99B
Illumina provides sequencing and array-based solutions for genetic analysis, which are crucial in cancer research and diagnostics, making it a competitor in the genomics space.

About

The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants for cancer patients. The company was founded in 2007 and is based in Cerritos, California.
Show more...
CEO
Dr. Daniel Virnich FACHE, M.B.A., M.D.
Employees
825
Country
US
ISIN
US68236X1182

Listings

0 Comments

Share your thoughts

FAQ

What is Oncology Institute Inc) stock price today?
The current price of TOIIW is $0.05 USD — it has increased by +4.91% in the past 24 hours. Watch Oncology Institute Inc) stock price performance more closely on the chart.
What is Oncology Institute Inc) stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Oncology Institute Inc) stocks are traded under the ticker TOIIW.
Is Oncology Institute Inc) stock price growing?
TOIIW stock has risen by +0.99% compared to the previous week, the month change is a -34.62% fall, over the last year Oncology Institute Inc) has showed a +63.93% increase.
What is Oncology Institute Inc) market cap?
Today Oncology Institute Inc) has the market capitalization of 4.52M
When is the next Oncology Institute Inc) earnings date?
Oncology Institute Inc) is going to release the next earnings report on May 13, 2026.
What were Oncology Institute Inc) earnings last quarter?
TOIIW earnings for the last quarter are -0.06 USD per share, whereas the estimation was -0.09 USD resulting in a +33.33% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Oncology Institute Inc) revenue for the last year?
Oncology Institute Inc) revenue for the last year amounts to 786.82M USD.
What is Oncology Institute Inc) net income for the last year?
TOIIW net income for the last year is -129.33M USD.
How many employees does Oncology Institute Inc) have?
As of April 02, 2026, the company has 825 employees.
In which sector is Oncology Institute Inc) located?
Oncology Institute Inc) operates in the Health Care sector.
When did Oncology Institute Inc) complete a stock split?
Oncology Institute Inc) has not had any recent stock splits.
Where is Oncology Institute Inc) headquartered?
Oncology Institute Inc) is headquartered in Cerritos, US.